Wuhan Research and Development Base has resumed operations

    April 1, 2020 -- Shenzhen Profoundview Wuhan Research and Development Base (Wuhan Vase Conduct Scientific Research Co., LTD.) will officially resume operation, and relevant arrangements will strictly follow the guidance of the government on disease control and epidemic prevention. Wuhan RESEARCH and Development Base mainly for the company's a series of new drug project synthesis, analysis, preparation research, will be as soon as possible after the resumption of work to improve the project development progress. So far, Shenzhen deep see has fully resumed normal operations. At the same time, the company is actively taking preventive measures to ensure the health and safety of staff at the base.

    Prior to the resumption of work of wuhan R&D base, shenzhen headquarters made full use of network resources to make deployment of the company's development strategy: The R&D center adjusted the project schedule according to the actual situation, searched and studied relevant literature during the shutdown of the epidemic, and considered the r&d plan; The comprehensive management Department pays close attention to the mental dynamics and health status of employees, resuming various policies, reserving corresponding personnel according to the needs of the project, actively coping with the impact caused by the epidemic, effectively reducing and minimizing the risk caused by unexpected shutdown as far as possible.

    In the future, we will continue to carry forward the spirit of scientific research, do new drugs, do good drugs, for the well-being of patients -- this is also the company has been adhering to the original heart since its establishment.